IL2RG and myeloid leukemia: For example, correction of a point mutation in interleukin 2 receptor, gamma (IL2RG) was accomplished in K562 cells, an immortalized myelogenous leukemia human cell line, as well as in primary human T-cells and human CD34+ cells [23], [24].